GLP-1 Receptor Agonists for Obesity: Personal and Professional Perspectives

Speaker(s)

• 

  John Buse, MD, PhD

  Verne S. Caviness Distinguished Professor; Chief, Division of Endocrinology
  University of North Carolina School of Medicine

  Disclosure: Disclosure(s): Alkahest: Consultant (Ongoing)
  Altimmune: Consultant (Ongoing)
  Anji: Consultant (Ongoing)
  AstraZeneca: Consultant (Ongoing)
  Bayer: Consultant (Ongoing)
  Biomea Fusion Inc: Consultant (Ongoing)
  Boehringer-Ingelheim: Consultant (Ongoing)
  CeQur: Consultant (Ongoing)
  Cirius Therapeutics Inc: Consultant (Ongoing)
  Dexcom: Grant/Research Support (Ongoing)
  Eli Lilly and Co.: Consultant (Ongoing)
  GentiBio: Consultant (Ongoing)
  Glycadia: Consultant (Ongoing)
  Glyscend: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
  Janssen: Consultant (Ongoing)
  LipoScience: Consultant (Ongoing)
  MannKind: Consultant (Ongoing)
  Medtronic: Grant/Research Support (Ongoing)
  Mellitus Health: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
  Moderna: Consultant (Ongoing)
  NovaTarg: Grant/Research Support (Ongoing)
  Novo Nordisk: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Pendulum Therapeutics: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
  PhaseBio: Stock Shareholder (excluding mutual funds) (Ongoing)
  Praetego: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
  Sanofi Aventis: Grant/Research Support (Ongoing)
  Stability Health: Consultant (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)
  Tolerion: Grant/Research Support (Ongoing)
  Valo: Consultant (Ongoing)
  vTv Therapeutics: Grant/Research Support (Ongoing)
  Zealand Pharma: Consultant (Ongoing)